Login / Signup

[Clinical courses and costs for hospitalizations of potentially immunocompromised COVID-19 patients in Germany].

Dennis HäcklMarc PignotPhi Long DangVictoria LauenrothFungwe JahClemens-Martin Wendtner
Published in: Deutsche medizinische Wochenschrift (1946) (2024)
 The risk group is vulnerable to COVID-19 and requires additional resources in the German hospital sector. This results in a need for further protective measures. Further studies are needed to evaluate the impact of different viral variants, active and passive immunizations, and therapies on clinical COVID-19 courses and their costs.
Keyphrases
  • sars cov
  • coronavirus disease
  • healthcare
  • respiratory syndrome coronavirus
  • emergency department
  • copy number
  • dna methylation
  • intensive care unit
  • adverse drug
  • acute care
  • genome wide